Patents by Inventor John Todd Schiller
John Todd Schiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12029794Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: GrantFiled: December 2, 2021Date of Patent: July 9, 2024Assignees: Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20240216527Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: March 14, 2024Publication date: July 4, 2024Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Patent number: 11806406Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: GrantFiled: August 5, 2021Date of Patent: November 7, 2023Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20220387619Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: August 5, 2021Publication date: December 8, 2022Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Serv.Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20220313720Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.Type: ApplicationFiled: November 17, 2021Publication date: October 6, 2022Inventors: Roy Lobb, Paul Rennert, John Todd Schiller
-
Publication number: 20220152217Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.Type: ApplicationFiled: April 11, 2018Publication date: May 19, 2022Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human ServiceInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
-
Publication number: 20220088216Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: December 2, 2021Publication date: March 24, 2022Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Patent number: 11207339Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.Type: GrantFiled: October 28, 2016Date of Patent: December 28, 2021Assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Aleta Biotherapeutics Inc.Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
-
Publication number: 20210393797Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: August 5, 2021Publication date: December 23, 2021Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20210290778Abstract: Some embodiments of the present disclosure are directed to methods and compositions for the treatment of tumors, using a combination of immunotherapeutic agents and tumor-targeting viral capsid protein assemblages comprising anti-cancer molecules conjugated to viral capsid proteins.Type: ApplicationFiled: April 11, 2018Publication date: September 23, 2021Applicants: Aura Biosciences, Inc., The USA, as Represented by the Secretary, Department of Health and Human ServiceInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines
-
Patent number: 11110181Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: GrantFiled: January 31, 2020Date of Patent: September 7, 2021Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20200188529Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: January 31, 2020Publication date: June 18, 2020Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Patent number: 10588984Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: GrantFiled: September 26, 2018Date of Patent: March 17, 2020Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20190083647Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: September 26, 2018Publication date: March 21, 2019Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human Ser.Inventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Patent number: 10117947Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: GrantFiled: September 18, 2014Date of Patent: November 6, 2018Assignees: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
-
Publication number: 20180311374Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a papillomavirus particle or soluble papillomavirus protein that targets a tumor, and delivering to the subject an immune cell expressing a receptor that binds to a surface antigen of the papillomavirus particle or soluble papillomavirus protein, respectively.Type: ApplicationFiled: October 28, 2016Publication date: November 1, 2018Applicants: The United States of America, as represented by the Secretary, Department of Health and Human Serv, Aleta Biotherapeutics, Inc.Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
-
Publication number: 20180311269Abstract: Some embodiments of the present disclosure are directed to methods that include delivering to a subject a nucleic acid encoding an antigen, wherein the nucleic acid is delivered via a tumor-selective vehicle or via intratumoral injection, and delivering to the subject an immune cell expressing a receptor that binds to the antigen.Type: ApplicationFiled: October 28, 2016Publication date: November 1, 2018Applicants: The United States of America, as represented by the Secretary, Dept. of Health and Human Service, Aleta Biotherapeutics, Inc.Inventors: Roy Lobb, Paul David Rennert, John Todd Schiller
-
Publication number: 20160228568Abstract: The present disclosure is directed to methods and compositions for the diagnosis and/or treatment of tumors, such as ocular tumors, using virus-like particles conjugated to photosensitive molecules.Type: ApplicationFiled: September 18, 2014Publication date: August 11, 2016Applicants: Aura Biosciences, Inc., The United States of America, as represented by the Secretary, Department of Health and Human ServInventors: Elisabet de los Pinos, John Todd Schiller, Rhonda C. Kines, John MacDougall
